BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11387667)

  • 1. [Visceral candidiasis].
    Herbrecht R; Zamfir A; Letscher-Bru V
    Rev Prat; 2001 Apr; 51(7):725-30. PubMed ID: 11387667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
    Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
    J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
    Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
    Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
    Thomas F; Mebtouche B; Clavier H; Kalfon P
    Rev Pneumol Clin; 2000 Feb; 56(1):37-40. PubMed ID: 10740113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
    Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II
    Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter-related fungemia caused by Candida intermedia.
    Ruan SY; Chien JY; Hou YC; Hsueh PR
    Int J Infect Dis; 2010 Feb; 14(2):e147-9. PubMed ID: 19497773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight.
    Kaufman D; Boyle R; Hazen KC; Patrie JT; Robinson M; Grossman LB
    J Pediatr; 2005 Aug; 147(2):172-9. PubMed ID: 16126045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep Candida infections in the neutropenic and non-neutropenic host: an ISHAM symposium.
    Tiraboschi IN; Bennett JE; Kauffman CA; Rex JH; Girmenia C; Sobel JD; Menichetti F
    Med Mycol; 2000; 38 Suppl 1():199-204. PubMed ID: 11204146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
    Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida glabrata fungemia cured by antibiotic-lock therapy: case report and short review.
    Angel-Moreno A; Boronat M; Bolaños M; Carrillo A; González S; Pérez Arellano JL
    J Infect; 2005 Oct; 51(3):e85-7. PubMed ID: 16230210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of antifungal prophylaxis on the gastrointestinal yeast colonisation in patients with haematological malignancies].
    Rimek D; Redetzke K; Kappe R
    Mycoses; 2006; 49 Suppl 2():18-23. PubMed ID: 17022757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment of invasive fungal infection in very low birthweight infants.
    Brecht M; Clerihew L; McGuire W
    Arch Dis Child Fetal Neonatal Ed; 2009 Jan; 94(1):F65-9. PubMed ID: 18838467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retrospective evaluation of the cases with Candida famata fungemia in a burn unit].
    Turunç T; Demiroğlu YZ; Alişkan H; Colakoğlu S; Arslan H
    Mikrobiyol Bul; 2009 Jan; 43(1):71-6. PubMed ID: 19334382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Visceral mycotic infections. In clinical practice].
    André MH; Lortholary O
    Rev Prat; 2001 Apr; 51(7):758-60. PubMed ID: 11387673
    [No Abstract]   [Full Text] [Related]  

  • 19. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
    Garey KW; Rege M; Pai MP; Mingo DE; Suda KJ; Turpin RS; Bearden DT
    Clin Infect Dis; 2006 Jul; 43(1):25-31. PubMed ID: 16758414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central venous catheter-associated fungemia secondary to mucormycosis.
    Chan-Tack KM; Nemoy LL; Perencevich EN
    Scand J Infect Dis; 2005; 37(11-12):925-7. PubMed ID: 16308234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.